HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.

AbstractOBJECTIVES:
Aspirin (acetylsalicylic acid) or ibuprofen [2-(4-isobutyl-phenyl)-propionic acid] was administered to mice undergoing treatment of tuberculosis infection with pyrazinamide to determine if these non-steroidal anti-inflammatory drugs (NSAIDs) enhance pyrazinamide activity in vivo.
METHODS:
BALB/c mice were infected with Mycobacterium tuberculosis H37Rv through aerosol exposure. Mice were treated orally with aspirin, ibuprofen or pyrazinamide, alone and in combination. The impact of daily administration of these drugs for 1 month was determined by enumerating viable bacteria in the lung and spleen.
RESULTS:
Aspirin or ibuprofen alone at 20 mg/kg per day had little effect on tuberculosis infection after 1 month of treatment, while pyrazinamide at 150 mg/kg per day led to a reduction of about 1.5 log(10) cfu in the lung and 2 log(10) cfu in the spleen compared with the control. Simultaneous administration of either aspirin or ibuprofen with pyrazinamide resulted in a further decrease of about 0.4 log(10) cfu in the lung and more than 1 log(10) cfu in the spleen compared with mice receiving pyrazinamide alone. All spleens in the pyrazinamide-only treatment group were positive for infection. Of mice treated with both aspirin and pyrazinamide, two of five spleens were negative for colony formation, with a lower limit of detection of 0.90 log(10) cfu per organ. Three of five mice given ibuprofen and pyrazinamide had culture-negative spleens.
CONCLUSIONS:
Aspirin and ibuprofen enhance the effect of pyrazinamide during the initial phase of tuberculosis treatment in the mouse model. Further investigation is necessary to determine the impact of NSAIDs on long-term treatment with pyrazinamide and other antituberculosis drugs in the mouse model of tuberculosis infection and the clinical implications of these findings on tuberculosis treatment in humans.
AuthorsSean T Byrne, Steven M Denkin, Ying Zhang
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 59 Issue 2 Pg. 313-6 (Feb 2007) ISSN: 0305-7453 [Print] England
PMID17185297 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antitubercular Agents
  • Pyrazinamide
  • Aspirin
  • Ibuprofen
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, therapeutic use)
  • Antitubercular Agents (administration & dosage, therapeutic use)
  • Aspirin (administration & dosage, therapeutic use)
  • Disease Models, Animal
  • Drug Synergism
  • Female
  • Ibuprofen (administration & dosage, therapeutic use)
  • Mice
  • Mice, Inbred BALB C
  • Mycobacterium tuberculosis (drug effects, growth & development)
  • Pyrazinamide (administration & dosage, therapeutic use)
  • Tuberculosis (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: